CIALIS 5 MG TABLET
FDA nonproprietary name: tadalafil
For 30 tablets
Pharmacies pay
$276.13 filed
30 × $9.20446 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$290.48 filed
30 × $9.68261 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.1× estimated
Medicare paid 1.1× what pharmacies pay.
Part D averages every strength and form sold under “Cialis” / “Tadalafil” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$322.55 estimated
$276.13 + $41.42 (15%) + $5.00 fee per fill = $322.55
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CIALIS 5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tadalafil, under the trade name “Cialis”.
FDA gives its dosage form as tablet, film coated and its route as oral.
The labeler, the company named on the label, is Eli Lilly and Company.
FDA’s Established Pharmacologic Class for it is Phosphodiesterase 5 Inhibitor.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00002-4462-30.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $276.13 for 30 tablets (30 × $9.20446 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.10319 per EA filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 00002-4462-30 · Eli Lilly and Company · $9.20446 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name tadalafil with CIALIS 5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ALYQ 20 MG TABLET | $0.14633 per EA filed | $17.34198 per EA filed |
| CIALIS 5 MG TABLET this page | $9.20446 per EA filed | $9.68261 per EA filed |
| CIALIS 10 MG TABLET | $53.6874 per EA filed | $9.68261 per EA filed |
| CIALIS 20 MG TABLET | $53.82543 per EA filed | $9.68261 per EA filed |
| TADALAFIL 2.5 MG TABLET | $0.11265 per EA filed | We don’t know yet |
| TADALAFIL 5 MG TABLET | $0.10319 per EA filed | We don’t know yet |
| TADALAFIL 10 MG TABLET | $0.15341 per EA filed | We don’t know yet |
| TADALAFIL 20 MG TABLET | $0.14633 to $0.16709 per EA filed | We don’t know yet |
| TADLIQ 20 MG/5 ML SUSPENSION | $13.59311 per ML filed | $12.21944 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23, 2026-10-01 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $9.20446 per EA filed.
Of the 17 other products in FDA’s Phosphodiesterase 5 Inhibitor class priced per EA, 5 have a higher middle NADAC price and 12 a lower one. The one in the middle is TADALAFIL 20 MG TABLET, at $0.16709 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $290.48 for 30 tablets, at an average of $9.68261 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cialis” and “Tadalafil”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 7,402 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: TADALAFIL 5 MG TABLET. Ask your pharmacist or prescriber; do not switch on your own.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CIALIS 5 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cialis / Tadalafil: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.